| Year |
Citation |
Score |
| 2022 |
Kacen A, Javitt A, Kramer MP, Morgenstern D, Tsaban T, Shmueli MD, Teo GC, da Veiga Leprevost F, Barnea E, Yu F, Admon A, Eisenbach L, Samuels Y, Schueler-Furman O, Levin Y, et al. Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nature Biotechnology. PMID 36203013 DOI: 10.1038/s41587-022-01464-2 |
0.393 |
|
| 2022 |
Solomon A, Alteber Z, Bassan D, Sharbi-Yunger A, Esbit S, Tzehoval E, Eisenbach L. On the development of a neoantigen vaccine for the prevention of Lynch Syndrome. International Journal of Cancer. PMID 35179790 DOI: 10.1002/ijc.33971 |
0.426 |
|
| 2021 |
Bassan D, Gozlan YM, Sharbi-Yunger A, Tzehoval E, Greenstein E, Bitan L, Friedman N, Eisenbach L. Avidity optimization of a MAGE-A1 specific TCR with somatic hypermutation. European Journal of Immunology. PMID 33835499 DOI: 10.1002/eji.202049007 |
0.366 |
|
| 2019 |
Wolf Y, Bartok O, Patkar S, Eli GB, Cohen S, Litchfield K, Levy R, Jiménez-Sánchez A, Trabish S, Lee JS, Karathia H, Barnea E, Day CP, Cinnamon E, Stein I, ... ... Eisenbach L, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. PMID 31522890 DOI: 10.1016/J.Cell.2019.08.032 |
0.512 |
|
| 2019 |
Bassan D, Gozlan YM, Sharbi-Yunger A, Tzehoval E, Eisenbach L. Optimizing T cell receptor avidity with somatic hypermutation. International Journal of Cancer. PMID 31381134 DOI: 10.1002/Ijc.32612 |
0.519 |
|
| 2018 |
Sharbi-Yunger A, Grees M, Gal C, Bassan D, Eichmüller SB, Tzehoval E, Utikal J, Umansky V, Eisenbach L. A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival. International Journal of Cancer. PMID 30106470 DOI: 10.1002/Ijc.31795 |
0.544 |
|
| 2018 |
Grees M, Sharbi-Yunger A, Evangelou C, Baumann D, Cafri G, Tzehoval E, Eichmüller SB, Offringa R, Utikal J, Eisenbach L, Umansky V. Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. Oncoimmunology. 7: e1445457. PMID 29900058 DOI: 10.1080/2162402X.2018.1445457 |
0.539 |
|
| 2018 |
Zupančič E, Curato C, Kim JS, Yeini E, Porat Z, Viana AS, Globerson-Levin A, Waks T, Eshhar Z, Moreira JN, Satchi-Fainaro R, Eisenbach L, Jung S, Florindo HF. Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29306001 DOI: 10.1016/J.Nano.2017.12.011 |
0.552 |
|
| 2017 |
Alteber Z, Sharbi-Yunger A, Pevsner-Fischer M, Blat D, Roitman L, Tzehoval E, Elinav E, Eisenbach L. The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota. Immunology and Cell Biology. PMID 29356071 DOI: 10.1111/Imcb.12000 |
0.364 |
|
| 2016 |
Sharbi-Yunger A, Grees M, Tzehoval E, Utikal J, Umansky V, Eisenbach L. mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model. Oncoimmunology. 5: e1160183. PMID 27471629 DOI: 10.1080/2162402X.2016.1160183 |
0.549 |
|
| 2015 |
Cafri G, Sharbi-Yunger A, Tzehoval E, Alteber Z, Gross T, Vadai E, Margalit A, Gross G, Eisenbach L. mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1391-400. PMID 25997427 DOI: 10.1038/Mt.2015.90 |
0.486 |
|
| 2015 |
Cafri G, Sharbi-Yunger A, Tzehoval E, Alteber Z, Gross T, Vadai E, Margalit A, Gross G, Eisenbach L. MRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor Immunity Molecular Therapy. 23: 1391-1400. DOI: 10.1038/mt.2015.90 |
0.365 |
|
| 2014 |
Alteber Z, Azulay M, Cafri G, Vadai E, Tzehoval E, Eisenbach L. Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity. Cancer Immunology, Immunotherapy : Cii. 63: 369-80. PMID 24452202 DOI: 10.1007/S00262-014-1520-4 |
0.555 |
|
| 2013 |
Cafri G, Margalit A, Tzehoval E, Eisenbach L, Gross G. Development of novel genetic cancer vaccines based on membrane-attached β2 microglobulin Annals of the New York Academy of Sciences. 1283: 87-90. PMID 23387369 DOI: 10.1111/Nyas.12017 |
0.526 |
|
| 2013 |
Cafri G, Sharbi-Yunger A, Tzehoval E, Eisenbach L. Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptides. Plos One. 8: e55583. PMID 23383339 DOI: 10.1371/Journal.Pone.0055583 |
0.526 |
|
| 2013 |
Gozlan YM, Tzehoval E, Eisenbach L. “First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P11 |
0.497 |
|
| 2013 |
Makovitzki-Avraham E, Daniel-Carmi V, Alteber Z, Farago M, Tzehoval E, Eisenbach L. The human ISG12a gene is a novel caspase dependent and p53 independent pro-apoptotic gene, that is overexpressed in breast cancer Cell Biology International Reports. 20: 37-46. DOI: 10.1002/Cbi3.10009 |
0.313 |
|
| 2012 |
Cohen N, Margalit R, Pevsner-Fischer M, Yona S, Jung S, Eisenbach L, Cohen IR. Mouse dendritic cells pulsed with capsular polysaccharide induce resistance to lethal pneumococcal challenge: roles of T cells and B cells. Plos One. 7: e39193. PMID 22723962 DOI: 10.1371/Journal.Pone.0039193 |
0.406 |
|
| 2011 |
Volovitz I, Marmor Y, Azulay M, Machlenkin A, Goldberger O, Mor F, Slavin S, Ram Z, Cohen IR, Eisenbach L. Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 5452-62. PMID 21998458 DOI: 10.4049/Jimmunol.1003946 |
0.78 |
|
| 2011 |
Cafri G, Amram E, Rinott G, Koifman G, Fishman S, Keisari Y, Tzehoval E, Margalit A, Eisenbach L, Gross G. Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene. International Immunology. 23: 453-61. PMID 21652516 DOI: 10.1093/Intimm/Dxr033 |
0.436 |
|
| 2010 |
Volovitz I, Marmor Y, Mor F, Flügel A, Odoardi F, Eisenbach L, Cohen IR. T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells. Journal of Autoimmunity. 35: 135-44. PMID 20580204 DOI: 10.1016/J.Jaut.2010.05.003 |
0.748 |
|
| 2009 |
Volovitz I, Mor F, Machlenkin A, Machlenkin A, Goldberger O, Marmor Y, Eisenbach L, Cohen IR, Cohen I. T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis. Immunology. 128: 92-102. PMID 19689739 DOI: 10.1111/J.1365-2567.2009.03074.X |
0.759 |
|
| 2009 |
Merbl Y, Itzchak R, Vider-Shalit T, Louzoun Y, Quintana FJ, Vadai E, Eisenbach L, Cohen IR. A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice. Plos One. 4: e6053. PMID 19557135 DOI: 10.1371/Journal.Pone.0006053 |
0.453 |
|
| 2008 |
Zhang QJ, Li XL, Wang D, Huang XC, Mathis JM, Duan WM, Knight D, Shi R, Glass J, Zhang DQ, Eisenbach L, Jefferies WA. Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. Plos One. 3: e3097. PMID 18769733 DOI: 10.1371/Journal.Pone.0003097 |
0.572 |
|
| 2008 |
Goldberger O, Volovitz I, Machlenkin A, Vadai E, Tzehoval E, Eisenbach L. Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Research. 68: 3450-7. PMID 18451173 DOI: 10.1158/0008-5472.Can-07-5006 |
0.797 |
|
| 2008 |
Machlenkin A, Uzana R, Frankenburg S, Eisenberg G, Eisenbach L, Pitcovski J, Gorodetsky R, Nissan A, Peretz T, Lotem M. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs. Cancer Research. 68: 2006-13. PMID 18339883 DOI: 10.1158/0008-5472.Can-07-3119 |
0.52 |
|
| 2008 |
Cohen N, Stolarsky-Bennun M, Amir-Kroll H, Margalit R, Nussbaum G, Cohen-Sfady M, Pevsner-Fischer M, Fridkin M, Bercovier H, Eisenbach L, Jung S, Cohen IR. Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive. Journal of Immunology (Baltimore, Md. : 1950). 180: 2409-18. PMID 18250450 DOI: 10.4049/Jimmunol.180.4.2409 |
0.34 |
|
| 2007 |
Tirosh B, Daniel-Carmi V, Carmon L, Paz A, Lugassy G, Vadai E, Machlenkin A, Bar-Haim E, Do MS, Ahn IS, Fridkin M, Tzehoval E, Eisenbach L. '1-8 Interferon inducible gene family': Putative colon carcinoma-associated antigens British Journal of Cancer. 97: 1655-1663. PMID 18071348 DOI: 10.1038/Sj.Bjc.6604061 |
0.412 |
|
| 2007 |
Issaeva I, Zonis Y, Rozovskaia T, Orlovsky K, Croce CM, Nakamura T, Mazo A, Eisenbach L, Canaani E. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Molecular and Cellular Biology. 27: 1889-903. PMID 17178841 DOI: 10.1128/Mcb.01506-06 |
0.309 |
|
| 2007 |
Machlenkin A, Azriel-Rosenfeld R, Volovitz I, Vadai E, Lev A, Paz A, Goldberger O, Reiter Y, Tzehoval E, Benhar I, Eisenbach L. Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunology, Immunotherapy : Cii. 56: 217-26. PMID 16738849 DOI: 10.1007/S00262-006-0184-0 |
0.772 |
|
| 2006 |
Stepensky D, Tzehoval E, Vadai E, Eisenbach L. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma Clinical and Experimental Immunology. 143: 139-149. PMID 16367945 DOI: 10.1111/J.1365-2249.2005.02965.X |
0.451 |
|
| 2006 |
Margalit A, Sheikhet HM, Carmi Y, Berko D, Tzehoval E, Eisenbach L, Gross G. Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin. Journal of Immunology (Baltimore, Md. : 1950). 176: 217-24. PMID 16365413 DOI: 10.4049/Jimmunol.176.1.217 |
0.461 |
|
| 2005 |
Machlenkin A, Paz A, Bar Haim E, Goldberger O, Finkel E, Tirosh B, Volovitz I, Vadai E, Lugassy G, Cytron S, Lemonnier F, Tzehoval E, Eisenbach L. Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy. Cancer Research. 65: 6435-42. PMID 16024648 DOI: 10.1158/0008-5472.Can-05-0133 |
0.761 |
|
| 2005 |
Machlenkin A, Goldberger O, Tirosh B, Paz A, Volovitz I, Bar-Haim E, Lee SH, Vadai E, Tzehoval E, Eisenbach L. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4955-61. PMID 16000595 DOI: 10.1158/1078-0432.Ccr-04-2422 |
0.773 |
|
| 2005 |
Berko D, Carmi Y, Cafri G, Ben-Zaken S, Sheikhet HM, Tzehoval E, Eisenbach L, Margalit A, Gross G. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 174: 2116-23. PMID 15699142 DOI: 10.4049/Jimmunol.174.4.2116 |
0.404 |
|
| 2004 |
Bar-Haim E, Paz A, Machlenkin A, Hazzan D, Tirosh B, Carmon L, Brenner B, Vadai E, Mor O, Stein A, Lemonnier FA, Tzehoval E, Eisenbach L. MAGE-A8 overexpression in transitional cell carcinoma of the bladder: Identification of two tumour-associated antigen peptides British Journal of Cancer. 91: 398-407. PMID 15213716 DOI: 10.1038/Sj.Bjc.6601968 |
0.367 |
|
| 2004 |
Qimron U, Paul L, Bar-Haim E, Bloushtain N, Eisenbach L, Staats HF, Porgador A. Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8(+) T cell population in different tissues. Vaccine. 22: 1390-4. PMID 15063561 DOI: 10.1016/J.Vaccine.2003.11.043 |
0.448 |
|
| 2004 |
Lee SH, Bar-Haim E, Goldberger O, Reich-Zeliger S, Vadai E, Tzehoval E, Eisenbach L. Expression of FasL by tumor cells does not abrogate anti-tumor CTL function. Immunology Letters. 91: 119-26. PMID 15019279 DOI: 10.1016/J.Imlet.2003.10.010 |
0.783 |
|
| 2004 |
Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Therapy. 11: 237-48. PMID 14739939 DOI: 10.1038/Sj.Cgt.7700678 |
0.776 |
|
| 2004 |
Markel G, Mussaffi H, Ling KL, Salio M, Gadola S, Steuer G, Blau H, Achdout H, de Miguel M, Gonen-Gross T, Hanna J, Arnon TI, Qimron U, Volovitz I, Eisenbach L, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood. 103: 1770-8. PMID 14604968 DOI: 10.1182/Blood-2003-06-2114 |
0.734 |
|
| 2004 |
Jung H, Ahn I, Do H, Lemonnier FA, Tirosh B, Tzehoval E, Vadai E, Eisenbach L, Do M. Adoptive Transfer of Colon Cancer Derived Peptide-specific CD8+T Cells in HHD Mice Immune Network. 4: 31. DOI: 10.4110/In.2004.4.1.31 |
0.492 |
|
| 2003 |
Denkberg G, Lev A, Eisenbach L, Benhar I, Reiter Y. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen. Journal of Immunology (Baltimore, Md. : 1950). 171: 2197-207. PMID 12928363 DOI: 10.4049/Jimmunol.171.5.2197 |
0.512 |
|
| 2003 |
Margalit O, Eisenbach L, Amariglio N, Kaminski N, Harmelin A, Pfeffer R, Shohat M, Rechavi G, Berger R. Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines British Journal of Cancer. 89: 314-319. PMID 12865923 DOI: 10.1038/Sj.Bjc.6600977 |
0.335 |
|
| 2003 |
Papo N, Shahar M, Eisenbach L, Shai Y. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice Journal of Biological Chemistry. 278: 21018-21023. PMID 12646578 DOI: 10.1074/Jbc.M211204200 |
0.422 |
|
| 2002 |
Cohen CJ, Hoffmann N, Farago M, Hoogenboom HR, Eisenbach L, Reiter Y. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cancer Research. 62: 5835-44. PMID 12384546 |
0.449 |
|
| 2002 |
Carmon L, Bobilev-Priel I, Brenner B, Bobilev D, Paz A, Bar-Haim E, Tirosh B, Klein T, Fridkin M, Lemonnier F, Tzehoval E, Eisenbach L. Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. The Journal of Clinical Investigation. 110: 453-62. PMID 12189239 DOI: 10.1172/Jci14071 |
0.417 |
|
| 2002 |
Markel G, Lieberman N, Katz G, Arnon TI, Lotem M, Drize O, Blumberg RS, Bar-Haim E, Mader R, Eisenbach L, Mandelboim O. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. Journal of Immunology (Baltimore, Md. : 1950). 168: 2803-10. PMID 11884449 DOI: 10.4049/Jimmunol.168.6.2803 |
0.425 |
|
| 2002 |
Barnea E, Beer I, Patoka R, Ziv T, Kessler O, Tzehoval E, Eisenbach L, Zavazava N, Admon A. Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. European Journal of Immunology. 32: 213-22. PMID 11782012 DOI: 10.1002/1521-4141(200201)32:1<213::Aid-Immu213>3.0.Co;2-8 |
0.495 |
|
| 2001 |
Zier K, Maddux JM, Johnson K, Sung M, Mandeli J, Eisenbach L, Schwartz M. Surrogate markers of antitumor responses: In vitro activation of T cells by autologous tumor peptides Clinical Cancer Research. 7. |
0.458 |
|
| 2000 |
Tirosh B, Fridkin M, Tzehoval E, Vadai E, Lemonnier FA, Eisenbach L. Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing Journal of Immunotherapy. 23: 622-630. PMID 11186150 DOI: 10.1097/00002371-200011000-00003 |
0.481 |
|
| 2000 |
Eisenbach L, Bar-Haim E, El-Shami K. Antitumor vaccination using peptide based vaccines Immunology Letters. 74: 27-34. PMID 10996624 DOI: 10.1016/S0165-2478(00)00245-5 |
0.447 |
|
| 2000 |
Carmon L, Tzehoval E, Tirosh B, El-Shami KM, Bar-Haim E, Vadai E, Feldman M, Eisenbach L. Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles Journal of Immunotherapy. 23: 344-352. PMID 10838663 DOI: 10.1097/00002371-200005000-00007 |
0.496 |
|
| 2000 |
Carmon L, El-Shami KM, Paz A, Pascolo S, Tzehoval E, Tirosh B, Koren R, Feldman M, Fridkin M, Lemonnier FA, Eisenbach L. Novel breast-tumor-associated MUC1-derived peptides: Characterization in D(b-)/- x β2 microglobulin (β2m) null mice transgenic for a chimeric HLA- A2.1/D(b)-β2 microglobulin single chain International Journal of Cancer. 85: 391-397. PMID 10652432 DOI: 10.1002/(Sici)1097-0215(20000201)85:3<391::Aid-Ijc16>3.0.Co;2-V |
0.442 |
|
| 2000 |
El-Shami KM, Tirosh B, Popovic D, Carmon L, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide International Journal of Cancer. 85: 236-242. PMID 10629083 DOI: 10.1002/(Sici)1097-0215(20000115)85:2<236::Aid-Ijc14>3.0.Co;2-5 |
0.531 |
|
| 2000 |
Zier K, Johnson K, Maddux JM, Sung M, Mandeli J, Eisenbach L, Schwartz M. IFNγ secretion following stimulation with total tumor peptides from autologous human tumors Journal of Immunological Methods. 241: 61-68. DOI: 10.1016/S0022-1759(00)00193-9 |
0.531 |
|
| 1999 |
El-Shami KM, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines Journal of Interferon and Cytokine Research. 19: 1391-1401. PMID 10638708 DOI: 10.1089/107999099312858 |
0.532 |
|
| 1999 |
Tirosh B, el-Shami K, Vaisman N, Carmon L, Bar-Haim E, Vadai E, Feldman M, Fridkin M, Eisenbach L. Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. Immunology Letters. 70: 21-8. PMID 10541048 DOI: 10.1016/S0165-2478(99)00115-7 |
0.433 |
|
| 1999 |
El-Shami K, Tirosh B, Bar-Haîm E, Carmon L, Vadai E, Fridkin M, Feldman M, Eisenbach L. MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope European Journal of Immunology. 29: 3295-3301. PMID 10540341 DOI: 10.1002/(Sici)1521-4141(199910)29:10<3295::Aid-Immu3295>3.0.Co;2-N |
0.559 |
|
| 1998 |
Popovic D, El-Shami KM, Vadai E, Feldman M, Tzehoval E, Eisenbach L. Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12 Clinical and Experimental Metastasis. 16: 623-632. PMID 9932609 DOI: 10.1023/A:1006508413070 |
0.485 |
|
| 1998 |
Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L. Retracted Correction: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma Nature. 392: 311-311. PMID 9767010 DOI: 10.1038/32713 |
0.317 |
|
| 1998 |
Eisenbach L, Mandelboim O, Bar-Haim E, Carmon L, Copcow H, El-Shami K, Paz A, Popovic D, Vadai E, Tzehoval E, Feldman M, Fridkin M. Tumor-associated antigen peptides as anti-metastatic vaccines Letters in Peptide Science. 5: 323-328. DOI: 10.1007/Bf02443479 |
0.507 |
|
| 1997 |
Mandelboim O, Bar-Haim E, Vadai E, Fridkin M, Eisenbach L. Identification of Shared Tumor-Associated Antigen Peptides between Two Spontaneous Lung Carcinomas Journal of Immunology. 159: 6030-6036. PMID 9550401 |
0.361 |
|
| 1997 |
Fitzer-Attas CJ, Do MS, Feigelson S, Vadai E, Feldman M, Eisenbach L. Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells Oncogene. 15: 1545-1554. PMID 9380406 DOI: 10.1038/Sj.Onc.1201321 |
0.348 |
|
| 1997 |
Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, Kimchi A. DAP kinase links the control of apoptosis to metastasis Nature. 390: 180-184. PMID 9367156 DOI: 10.1038/36599 |
0.327 |
|
| 1996 |
Eisenbach L. Curing metastases? Gene and peptide therapy Current Topics in Microbiology and Immunology. 213: 84-100. PMID 8815012 DOI: 10.1007/978-3-642-80071-9_6 |
0.479 |
|
| 1995 |
Mandelboim O, Vadai E, Feldman M, Eisenbach L. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells Gene Therapy. 2: 757-765. PMID 8750016 |
0.417 |
|
| 1995 |
Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Combined Vaccination with Major Histocompatibility Class I and Interleukin 2 Gene-transduced Melanoma Cells Synergizes the Cure of Postsurgical Established Lung Metastases Cancer Research. 55: 4941-4949. PMID 7585534 |
0.334 |
|
| 1995 |
Mandelboim O, Vadai E, Fridkin M, Katz-Hillel A, Feldman M, Berke G, Eisenbach L. Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides Nature Medicine. 1: 1179-1183. PMID 7584991 DOI: 10.1038/Nm1195-1179 |
0.432 |
|
| 1995 |
Revel M, Katz A, Eisenbach L, Feldman M, Haran-Ghera N, Harroch S, Chebath J. Interleukin-6: Effects on tumor models in mice and on the cellular regulation of transcription factor IRF-1 Annals of the New York Academy of Sciences. 762: 342-356. PMID 7545371 DOI: 10.1111/J.1749-6632.1995.Tb32338.X |
0.361 |
|
| 1995 |
Eisenbach L, Mandelboim O, Porgador A, Plaksin D, Fridkin M. 36 Gene and peptide therapy of tumor metastases in murine models European Journal of Cancer. 31: S8. DOI: 10.1016/0959-8049(95)95288-H |
0.451 |
|
| 1995 |
Eisenbach L, Mandelboim O, Berke G, Fridkin M, Progador A, Plaksin D, Feldman M. Gene therapy and peptide therapy of tumor metastasis Journal of Cancer Research and Clinical Oncology. 121: S37-S37. DOI: 10.1007/Bf02559902 |
0.348 |
|
| 1994 |
Porgador A, Feldman M, Eisenbach L. Immunotherapy of tumor metastasis via gene therapy Natural Immunity. 13: 113-130. PMID 8173233 |
0.413 |
|
| 1994 |
Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma Nature. 369: 67-71. PMID 8164742 DOI: 10.1038/369067A0 |
0.409 |
|
| 1994 |
Fitzer-Attas C, Eldar H, Eisenbach L, Livneh E. The expression of PDGF-α but not PDGF-β receptors is suppressed in Swiss/3T3 fibroblasts over-expressing protein kinase C-α Febs Letters. 342: 165-170. PMID 8143871 DOI: 10.1016/0014-5793(94)80493-1 |
0.305 |
|
| 1994 |
Plaksin D, Porgador A, Vadai E, Feldman M, Schirrmacher V, Eisenbach L. Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV) International Journal of Cancer. 59: 796-801. PMID 7989121 DOI: 10.1002/Ijc.2910590615 |
0.52 |
|
| 1993 |
Plaksin D, Baeuerle PA, Eisenbach L. KBF1 (p50 NF-κB homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells Journal of Experimental Medicine. 177: 1651-1662. PMID 8496683 DOI: 10.1084/Jem.177.6.1651 |
0.375 |
|
| 1993 |
Katz A, Shulman LM, Revel M, Feldman M, Eisenbach L. Combined therapy with IL-6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas International Journal of Cancer. 53: 812-818. PMID 8449606 DOI: 10.1002/Ijc.2910530518 |
0.469 |
|
| 1993 |
Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells Journal of Immunology. 150: 1458-1470. PMID 8432988 |
0.367 |
|
| 1993 |
Porgador A, Gansbacher B, Bannerji R, Tzehoval E, Gilboa E, Feldman M, Eisenbach L. Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells International Journal of Cancer. 53: 471-477. PMID 8428800 DOI: 10.1002/Ijc.2910530320 |
0.405 |
|
| 1993 |
Fitzer-Attas C, Feldman M, Eisenbach L. Expression of functionally intact PDGF-α receptors in highly metastatic 3LL Lewis lung carcinoma cells International Journal of Cancer. 53: 315-322. PMID 8425771 DOI: 10.1002/Ijc.2910530224 |
0.394 |
|
| 1993 |
Rabizadeh E, Shaklai M, Nudelman A, Eisenbach L, Rephaeli A. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug Febs Letters. 328: 225-229. PMID 8348968 DOI: 10.1016/0014-5793(93)80932-K |
0.31 |
|
| 1993 |
Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L. Abrogation of b16 melanoma metastases by long-term low-dose interleukin-6 therapy Journal of Immunotherapy. 13: 98-109. PMID 8318501 DOI: 10.1097/00002371-199302000-00004 |
0.413 |
|
| 1993 |
Porgador A, Tzehoval E, Vadai E, Feldman M, Eisenbach L. Immunotherapy via gene therapy: Comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-γ genes Journal of Immunotherapy. 14: 191-201. PMID 7905286 DOI: 10.1097/00002371-199310000-00005 |
0.442 |
|
| 1993 |
Fenig E, Nordenberg J, Lurie H, Angel P, Feldman M, Eisenbach L. Amplification of the expression of major histocompatibility class I antigens by inducers of differentiation and gamma interferon in murine and human solid tumor cell lines International Journal of Oncology. 2: 279-282. DOI: 10.3892/Ijo.2.2.279 |
0.487 |
|
| 1992 |
Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L. Interleukin 6 Gene Transfection into Lewis Lung Carcinoma Tumor Cells Suppresses the Malignant Phenotype and Confers Immunotherapeutic Competence against Parental Metastatic Cells Cancer Research. 52: 3679-3686. PMID 1617640 |
0.316 |
|
| 1992 |
Katz A, Feldman M, Eisenbach L. The use of [35S]methionine as a target cell label in long term cytotoxic assays Journal of Immunological Methods. 149: 255-260. PMID 1593137 DOI: 10.1016/0022-1759(92)90257-T |
0.368 |
|
| 1992 |
Fridkis-Hareli M, Abel L, Eisenbach L, Globerson A. Differentiation patterns of CD4/CD8 thymocyte subsets in cocultures of fetal thymus and lymphohemopoietic cells from c-fos transgenic and normal mice. Cellular Immunology. 141: 279-92. PMID 1576652 DOI: 10.1016/0008-8749(92)90148-I |
0.352 |
|
| 1992 |
Plaksin D, Gelber C, Eisenbach L. H-2Db gene transver into highly metastatic D122 cells results in tumor rejection in allogeneic recipients, but does not affect metastasis in syngeneic recipients. Implications for mechanisms of allorejection International Journal of Cancer. 52: 771-777. PMID 1428231 DOI: 10.1002/Ijc.2910520517 |
0.419 |
|
| 1992 |
Gelber C, Eisenbach L, Feldman M, Goodenow RS. T-Cell Subset Analysis of Lewis Lung Carcinoma Tumor Rejection: Heterogeneity of Effectors and Evidence for Negative Regulatory Lymphocytes Correlating with Metastasis Cancer Research. 52: 6507-6515. PMID 1423297 |
0.437 |
|
| 1992 |
Suh BS, Eisenbach L, Amsterdam A. Adenosine 3′,5′-monophosphate suppresses metastatic spread in nude mice of steroidogenic rat granulosa cells transformed by simian virus-40 and Ha-ras oncogene Endocrinology. 131: 526-532. PMID 1319328 DOI: 10.1210/Endo.131.1.1319328 |
0.435 |
|
| 1992 |
Revel M, Haran-Ghera N, Katz A, Eisenbach L, Feldman M, Slavin S. 88. Antitumor effects of human IL-6 in murine leukemia and solid tumor models Biomedicine & Pharmacotherapy. 46: 282. DOI: 10.1016/0753-3322(92)90173-5 |
0.344 |
|
| 1992 |
Suh B, Eisenbach L, Amsterdam A. 81. Cyclic AMP suppresses metastatic spread in nude mice of steroidogenic rat granulosa cells transformed by SV40 and Ha-ras oncogene Biomedicine & Pharmacotherapy. 46: 279. DOI: 10.1016/0753-3322(92)90166-5 |
0.313 |
|
| 1991 |
Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldman M. Expression of HLA-A,B,C Antigens on Primary and Metastatic Tumor Cell Populations of Human Carcinomas Cancer Research. 51: 6372-6380. PMID 1933900 |
0.419 |
|
| 1991 |
Eisenbach L, Feldman M. Tumor cell surface determinants in host immunity against metastases Seminars in Cancer Biology. 2: 179-188. PMID 1912526 |
0.464 |
|
| 1991 |
Porgador A, Brenner B, Vadai E, Feldman M, Eisenbach L. Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor International Journal of Cancer. 48: 54-60. PMID 1906054 DOI: 10.1002/Ijc.2910470713 |
0.42 |
|
| 1991 |
Gelber C, Eisenbach L, Feldman M, Goodenow RS. T-cell subset analysis of 3LL tumor growth International Journal of Cancer. 48: 69-72. PMID 1829721 DOI: 10.1002/Ijc.2910470715 |
0.502 |
|
| 1991 |
Feldman M, Eisenbach L. MHC class I genes controlling the metastatic phenotype of tumor cells Seminars in Cancer Biology. 2: 337-346. PMID 1773049 |
0.394 |
|
| 1991 |
Brosh N, Lotan M, Eisenbach L, Brocke S, Tartakovsky B. Fertility impairment and improved fetal survival induced by a tumor cell line in mice American Journal of Reproductive Immunology. 26: 47-51. PMID 1741939 DOI: 10.1111/J.1600-0897.1991.Tb00702.X |
0.494 |
|
| 1990 |
Kushtai G, Feldman M, Eisenbach L. Transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence International Journal of Cancer. 45: 1131-1136. PMID 2351488 DOI: 10.1002/Ijc.2910450624 |
0.358 |
|
| 1989 |
Porgador A, Feldman M, Eisenbach L. H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence Journal of Immunogenetics. 16: 291-303. PMID 2639904 DOI: 10.1111/J.1744-313X.1989.Tb00475.X |
0.397 |
|
| 1989 |
Martínez RD, Eisenbach L, Feldman M. Cytotoxic and proliferative effect of tobacco products on Lewis lung adenocarcinoma cells and spleen lymphocytes. Allergologia Et Immunopathologia. 17: 257-61. PMID 2610189 |
0.349 |
|
| 1989 |
Tzehoval E, Dagan S, Eisenbach L, Atsmon J, Feldman M. Immunogenic capacity of macrophage hybridomas European Journal of Immunology. 19: 89-96. PMID 2465907 DOI: 10.1002/Eji.1830190115 |
0.413 |
|
| 1988 |
Plaksin D, Gelber C, Feldman M, Eisenbach L. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2K(b) gene Proceedings of the National Academy of Sciences of the United States of America. 85: 4463-4467. PMID 3380801 DOI: 10.1073/Pnas.85.12.4463 |
0.407 |
|
| 1988 |
Feldman M, Plaksin D, Gelber K, Kushtai G, Eisenbach L. Control of MHC genes that regulate the metastatic phenotype of tumor cells Advances in Experimental Medicine and Biology. 233: 109-117. PMID 3223379 |
0.348 |
|
| 1988 |
Feldman M, Eisenbach L. What makes a tumor cell metastatic? Scientific American. 259: 60-65, 68, 85. PMID 2463669 DOI: 10.1038/Scientificamerican1188-60 |
0.48 |
|
| 1986 |
Eisenbach L, Kushtai G, Plaksin D, Feldman M. MHC genes and oncogenes controlling the metastatic phenotype of tumor cells Cancer Reviews. 1-18. |
0.355 |
|
| 1985 |
Eisenbach L, Segal S, Feldman M. Proteolytic Enzymes in tumor metastasis. I. Plasminogen activator in clones of lewis lung carcinoma and t10 sarcoma1, 2 Journal of the National Cancer Institute. 74: 77-85. PMID 3855489 DOI: 10.1093/Jnci/74.1.77 |
0.482 |
|
| 1985 |
Eisenbach L, Segal S, Feldman M. Proteolytic enzymes in tumor metastasis. II. Collagenase type iv activity in subcellular fractions of cloned tumor cell populations1, 2 Journal of the National Cancer Institute. 74: 87-93. PMID 2982056 DOI: 10.1093/Jnci/74.1.87 |
0.419 |
|
| 1985 |
Eisenbach L, Feldman M. Genes and antigens controlling tumor metastases Hamatologie Und Bluttransfusion. 29: 499-507. PMID 2411643 DOI: 10.1007/978-3-642-70385-0_101 |
0.547 |
|
| 1985 |
Eisenbach L, Hollander N, Segal S, Feldman M. The differential expression of class I major histocompatibility complex antigens controls the metastatic properties of tumor cells Transplantation Proceedings. 17: 729-734. |
0.363 |
|
| 1984 |
Eisenbach L, Hollander N, Greenfeld L, Yakor H, Segal S, Feldman M. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells. International Journal of Cancer. 34: 567-73. PMID 6490207 DOI: 10.1002/Ijc.2910340421 |
0.369 |
|
| 1983 |
Eisenbach L, Segal S, Feldman M. MHC imbalance and metastatic spread in Lewis lung carcinoma clones International Journal of Cancer. 32: 113-120. PMID 6862690 DOI: 10.1002/Ijc.2910320118 |
0.343 |
|
| 1983 |
Eisenbach L, Ramanathan R, Nelson DL. Biochemical studies of the excitable membrane of Paramecium tetraurelia. IX. Antibodies against ciliary membrane proteins Journal of Cell Biology. 97: 1412-1420. PMID 6415066 DOI: 10.1083/Jcb.97.5.1412 |
0.329 |
|
| 1983 |
Eisenbach L, De Baetselier P, Katzav S, Segal S, Feldman M. Immunogenetic control of metastatic competence of cloned tumor cell populations Symposium On Fundamental Cancer Research. 36: 101-121. PMID 6332357 |
0.318 |
|
| Show low-probability matches. |